H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine.
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
H1-receptor antagonists are the drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine.
azelastine hydrochloride
(CHEBI:2951)
has part
azelastine
(CHEBI:2950)
azelastine hydrochloride
(CHEBI:2951)
has role
anti-allergic agent
(CHEBI:50857)
azelastine hydrochloride
(CHEBI:2951)
has role
anti-asthmatic drug
(CHEBI:49167)
azelastine hydrochloride
(CHEBI:2951)
has role
bronchodilator agent
(CHEBI:35523)
azelastine hydrochloride
(CHEBI:2951)
has role
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor
(CHEBI:64964)
azelastine hydrochloride
(CHEBI:2951)
has role
H1-receptor antagonist
(CHEBI:37955)
azelastine hydrochloride
(CHEBI:2951)
has role
platelet aggregation inhibitor
(CHEBI:50427)
azelastine hydrochloride
(CHEBI:2951)
is a
hydrochloride
(CHEBI:36807)